Quick search:
Content Ideas
| Result | Content Idea | Research |
|---|---|---|
| Result | Content Idea | Research |
| 1 | FDA tells Merck to show more data for its OncoImmune COVID-19 drug as EUA pushed back |
|
| 2 | Merck KGaA earmarks $855M for Debiopharm's programmed cell death promoting drug in global licensing deal |
|
| 3 | Merck gets a PDUFA date for its chronic cough contender; Morphic shares skyrocket on the heels of PhI data rollout in IBD |
|
| 4 | Merck KGaA Bolsters Head and Neck Cancer Pipeline With Debiopharm Breakthrough Therapy |
|
| 5 | FDA accepts gefapixant for review in cough, positioning Merck to get head start on Bayer and Bellus |
|
| 6 | Merck to Acquire Pandion Therapeutics |
|
| 7 | Merck rolls first Gardasil TV commercial that pushes HPV vaccines for adults |
|
| 8 | Merck's OncoImmune COVID-19 Therapeutic Stuck at Starting Gate Pending Further Data |
|
| 9 | Artiva, fresh from Merck pact, raises $120M for NK therapy R&D |
|
| 10 | Ready to square off with Pfizer in next-gen pneumococcal vaccines, a Merck exec says competition's a good thing |
|
| 11 | Merck Inks Deal To Buy Pandion Therapeutics For $1.85B; Shares Skyrocket |
|
| 12 | Global Proteinase K Market Analysis Report 2020-2027 Featuring Key players |
|
| 13 | Merck: FDA To Review NDA For Gefapixant |
|
| 14 | UPDATE 1-Merck says FDA requires more data on its COVID-19 drug |
|
| 15 | Outspoken Merck CEO Kenneth Frazier, who challenged Trump on race issues, to retire this year |
|
| 16 | Merck Animal Health Completes Acquisition of Poultry Sense Limited |
|
| 17 | How Merck's Vaccine Lost the Covid Race |
|
| 18 | UPDATED: Merck takes a swing at the IL-2 puzzlebox with a $1.85B play for buzzy Pandion and its autoimmune hopefuls |
|
| 19 | Merck & Co makes the accelerated approval pathway its own |
|
| 20 | Merck's OncoImmune Covid-19 Therapeutic Requires Further Data |
|
| 21 | Merck & Company |
|
| 22 | After Merck, AstraZeneca Plc sells stake in a biotech company that developed COVID-19 vaccine: Report |
|
| 23 | The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants |
|
| 24 | Merck Animal Health acquires Poultry Sense flock-health product company |
|
| 25 | There's More to Merck's New 'Bean Counter' CEO Than First Appears |
|
| 26 | Biotech upstart adds a failed Merck KGaA drug to the pipeline, mapping new combo approach to MAPK pathway |
|
| 27 | Merck Q4 Earnings Preview: Keytruda And Gardasil In Focus |
|
| 28 | Data favor Merck, Eisai's Keytruda-Lenvima as the winner in kidney cancer, but window still open for Bristol Myers: analyst |
|
| 29 | Merck Animal Health acquires Poultry Sense |
|
| 30 | Merck acquires Pandion Therapeutics for $1.85B |
|
| 31 | ASCO GU: Merck, Eisai turn up the heat in kidney cancer with Keytruda-Lenvima survival data |
|
| 32 | Global Parkinson\'s Disease Drug Market 2021 – Merck, Akorn, GSK, Novartis, Boehringer Ingelheim – KSU | The Sentinel Newspaper |
|
| 33 | Merck Announces Fourth-Quarter and Full-Year 2020 Financial Results |
|
| 34 | FDA Adcom Gives Merck's Keytruda a Surprise Thumbs Down |
|
| 35 | Merck to acquire Pandion for $2 billion (NYSE:MRK) |
|
| 36 | Adult Vaccine Market Future Prospects 2026 | GlaxoSmithKline, Sanofi Pasteur, Merck |
|
| 37 | Ivermectin Medication Market Size 2021 | Industry Growth Analysis by Key Players – MERCK, Arbor Pharmaceuticals, Delta Pharma, Galderma, Edenbridge Pharmaceuticals |
|
| 38 | Merck to Present at the Cowen 41st Annual Health Care Conference |
|
| 39 | Gates, Merck and Novartis-backed Adjuvant Capital raises $300M for neglected diseases |
|
| 40 | AbbVie, Eli Lilly lead Big Pharma's 2020 market cap growth as Merck, Gilead lag |
|
| 41 | Merck/Eisai's Keytruda-Lenvima Combo Tops Standard Of Care In Late-Stage Kidney Cancer Study |
|
| 42 | Merck to provide CDMO services to Alteogen < Pharma < 기사본문 |
|
| 43 | Merck anti-baldness drug Propecia has long trail of suicide reports, records show |
|
| 44 | Police activity at Merck on Tuesday |
|
| 45 | Here’s Why Merck Is A Better Pick Over Johnson & Johnson Stock |
|
| 46 | Merck & Co. Inc. stock rises Monday, outperforms market |
|
| 47 | Merck to buy Pandion Therapeutics for USD 1.85 billion |
|
| 48 | Merck Knew About Suicides Linked To Propecia But Didn't Update Label, Unsealed Documents Show |
|
| 49 | Merck KGaA expands its deal with Pfizer/BioNTech with an eye on a key vaccine manufacturing bottleneck |
|
| 50 | Asco-GU – Merck’s Peloton gives Arrowhead a slipstream |
|
| 51 | Merck & Co. (MRK) Q4 2020 Earnings Call Transcript |
|
| 52 | Forbes Pharma's Blockchain Trials: Novartis, Merck Test The Tech Popularized By Bitcoin From fighting fake drugs |
|
| 53 | UPDATED: FDA panel admonishes Merck with a gentle — and rare — slapdown for rushing its pitch on an accelerated OK for adjuvant Keytruda in TNBC |
|
| 54 | Overcoming chemotherapy resistance in leukemia with a diarrhea drug from Merck |
|
| 55 | The future of mRNA, J&J's vaccine adcomm, Merck's $1.85B autoimmune bet and more |
|
| 56 | C-Suite Diversity Struggles As Merck’s CEO Ken Frazier Is Leaving |
|
| 57 | FDA blasts Merck's bid for adjuvant Keytruda in TNBC before adcomm, calling late-stage data 'questionable' |
|
| 58 | NKTR Stock Breaks Out; Plans Combo Study With Merck's Keytruda |
|
| 59 | General Reagents Market Status and Business Outlook 2020-2026: Merck, Thermo Fisher Scientific, VWR – KSU | The Sentinel Newspaper |
|
| 60 | Recombinant Vaccine Market to Eyewitness Massive Growth by 2026 | Merck & Co., Inc., Green Cross Corporation, Pfizer, Inc., Sanofi SA – KSU | The Sentinel Newspaper |
|
| 61 | Merck Animal Health Completes Poultry Sense Limited Acquisition |
|
| 62 | Recon: Merck to buy Pandion Therapeutics for $1.85B; Bahrain authorizes J&J vaccine |
|
| 63 | The Vanguard Health Care Fund Exits Medtronic, Merck & Co |
|
| 64 | Listen: 23andMe is going public & Merck's CEO is retiring |
|
| 65 | Merck & Co. Inc. stock rises Thursday, outperforms market |
|
| 66 | Oral Vaccine Market Size 2021 | Industry Growth Analysis by Key Players – Merck, Bibcol, Lanzhou Institute, GSK, Shanghai United Cell |
|
| 67 | Merck Sharp & Dohme FCU names next chief executive |
|
| 68 | Poxel Announces Completion of Arbitration with Merck Serono |
|
| 69 | Merck & Co, Indian Firms On Tackling Supply Chain Risks And A Hijack |
|
| 70 | FDA blasts Merck's Keytruda data for new breast cancer indication |
|
| 71 | Global Antidiabetic SGLT-2 Inhibitor Market 2021 – Pfizer, AstraZeneca, Johnson & Johnson, GlaxoSmithKline, Merck & Co – KSU | The Sentinel Newspaper |
|
| 72 | Merck, BioNTech to accelerate lipid supply for Covid-19 vaccine production |
|
| 73 | Merck purchases Poultry Sense Limited |
|
| 74 | The Life Science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the US and Canada |
|
| 75 | Merck KGaA matches Novartis with FDA green light for targeted lung cancer drug Tepmetko |
|
| 76 | Why Merck (MRK) is a Top Dividend Stock for Your Portfolio |
|
| 77 | Global Oropharyngeal Cancer Diagnosis and Therapeutics Market 2020 Key Regions – Merck, AB Science, VLPbio |
|
| 78 | Merck expects interim data on COVID-19 drug in first quarter |
|
| 79 | Global Reversine Market Insights, Forecast to 2027| Merck, STEMCELL Technologies, Cayman Chemical – The Bisouv Network |
|
| 80 | AbSci Announces Strategic Investment by Merck Global Health Innovation Fund |
|
| 81 | #WCLC21: Merck pokes Bristol Myers in the eye with Keytruda data showing safety red flags in Yervoy combo trial |
|
| 82 | Merck KGaA goes toe to toe with Novartis as FDA green-lights MET inhibitor |
|
| 83 | Hypogonadism Treatment: Market 2021 is Booming Worldwide with Key Players | Merck & Co., Inc, Sanofi, Laboratoires Genevrier, AbbVie Inc – The Bisouv Network |
|
| 84 | Regeneron wins FDA OK in lung cancer for immunotherapy rival to Merck's Keytruda |
|
| 85 | The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More |
|
| 86 | Merck: Positioned To Deliver For Dividend Investors In 2021 |
|
| 87 | Bioactive Materials Market 2021 Growing Demands and Precise Outlook – Thermo Fisher Scientific, Beckman Coulter, Abbott, Merck & Co – KSU | The Sentinel Newspaper |
|
| 88 | Bacterial Conjunctivitis Market to Register Exponential Growth During 2020 – 2027 | Key Players – Novartis, Merck, Pfizer. – KSU | The Sentinel Newspaper |
|
| 89 | Allergic Rhinitis Market – increasing demand with Industry Professionals: Merck KGaA, GSK group of companies, Sanofi – NeighborWebSJ |
|
| 90 | Why the three biggest vaccine makers failed on Covid-19 |
|
| 91 | Research of Hexamethylenediamine Market 2021-27 | ETHICON, BASF, DowDuPont, Toray Industries, MERCK KGAA |
|
| 92 | Liquid Sulfur Market Study Report (2021-2026), Competitive Analysis, Proposal Strategy, Potential Targets|AkzoNobel, Quadrimex, Merck Millipore, Martin Midstream, ConocoPhillips, etc – KSU | The Sentinel Newspaper |
|
| 93 | Merck & Co., Inc. to Host Earnings Call |
|
| 94 | Merck Mercuriadis faces the future… and stares down his critics |
|
| 95 | Isotope Labeled Compounds Market (COVID-19) to Witness Astonishing Growth by Forecast 2021-2027 |Merck KGaA, Urenco Limited, Isosciences, LLC (An Mdp Chemicals Company), Medical Isotopes, etc – KSU | The Sentinel Newspaper |
|
| 96 | Global Endocrine System Drug Market To Witness Huge Gains Over 2021-2026|Novo Nordisk, Sanofi, Merck, Eli Lilly, etc – KSU | The Sentinel Newspaper |
|
| 97 | Custom Assays Market by 2026 with Focusing on Leading Players like Promega, Bioassay, Merck, Thermo Fisher Scientific, R & D Systems, Fluidigm, Luminex, Roche, Qiagen – KSU | The Sentinel Newspaper |
|
| 98 | Biomarker Market Profiling key players: Inc. (US), Merck Millipore (US), Bio-Rad Laboratories – The Bisouv Network |
|
| 99 | And The UK's First 'Innovation Passport' Goes To... Merck's Rare Disease Drug Belzutifan |
|
| 100 | Tert-Amyl Methyl Ether Market 2021-2027 Study by BASF, Triveni Interchem, Eastman Chemicals, Merck KGaA – KSU | The Sentinel Newspaper |
|